418 related articles for article (PubMed ID: 1646329)
1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
2. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
[TBL] [Abstract][Full Text] [Related]
4. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
5. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
Pi XJ; Chen X
J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
Sargent CA; Sleph PG; Dzwonczyk S; Smith MA; Normandin D; Antonaccio MJ; Grover GJ
J Pharmacol Exp Ther; 1993 May; 265(2):609-18. PubMed ID: 8496812
[TBL] [Abstract][Full Text] [Related]
7. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
Przyklenk K; Kloner RA
Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
10. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
[TBL] [Abstract][Full Text] [Related]
11. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.
van Gilst WH; de Graeff PA; Wesseling H; de Langen CD
J Cardiovasc Pharmacol; 1986; 8(4):722-8. PubMed ID: 2427810
[TBL] [Abstract][Full Text] [Related]
12. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs.
Cushman DW; Wang FL; Fung WC; Harvey CM; DeForrest JM
Am J Hypertens; 1989 Apr; 2(4):294-306. PubMed ID: 2706094
[TBL] [Abstract][Full Text] [Related]
14. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
[TBL] [Abstract][Full Text] [Related]
15. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Carlsson L; Abrahamsson T
Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Giusti A; Uhr MR
Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Takeda H; Haneda T; Kikuchi K
Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
[TBL] [Abstract][Full Text] [Related]
18. [Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].
Becker BF; Reinholz N; Leipert B; Raschke P; Gerlach E
Klin Wochenschr; 1991; 69 Suppl 24():6-9. PubMed ID: 1650863
[TBL] [Abstract][Full Text] [Related]
19. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
[TBL] [Abstract][Full Text] [Related]
20. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
Schölkens BA; Linz W
Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
